Aytu BioPharma, Inc. ( AYTU) - Key Metrics
AYTU Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | $1.51 | -$1.05 | $0.37 | $0.36 |
| 2026Q1 | $1.47 | $0.21 | -$0.07 | -$0.07 |
| 2025Q4 | $2.23 | -$2.92 | $0.41 | $0.41 |
| 2025Q3 | $3.01 | $0.65 | -$1.05 | -$1.06 |
AYTU Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q2 | ? | -0.62 |
| 2026Q1 | ? | 2.26 |
| 2025Q4 | ? | -0.19 |
| 2025Q3 | ? | 0.46 |
AYTU
Price: $2.16
52 week price:
Earnings Per Share: -4.61 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 55600
Ebitda: -9.2 millionMarket Capitalization: 18.2 million